SCHEMBL7993409

SCHEMBL7993409

O=C(Cc1ccccc1)c1cc(=O)cco1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
AKR1B1 P15121 1/20 0.44
MAPT P10636 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
RAB9A P51151 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 2/20 0.42
KDM4E B2RXH2 1/20 0.42
SRD5A2 P31213 2/20 0.41
ERCC5 P28715 1/20 0.41
FEN1 P39748 1/20 0.41
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
GAA P10253 3/20 0.41
IDO1 P14902 1/20 0.41
CYP2C19 P33261 1/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1255897 0.80 ERCC5 (0.61) CES2CES1AKR1B1MAPTL3MBTL1
SCHEMBL546936 0.75 PTPN1 (0.39) CES2CES1AKR1B1L3MBTL1RAB9A
SCHEMBL19389863 0.70 ERCC5 (0.50) CES2CES1MAPTL3MBTL1RAB9A
SCHEMBL13629841 0.70 ALDH1A1 (0.38) CES2CES1MAPTL3MBTL1RAB9A
SCHEMBL3661961 0.70 CES2 (0.37) CES2CES1MAPTRAB9ASMN1; SMN2
SCHEMBL8830659 0.70 CES2 (0.37) CES2CES1RAB9ANPC1ALDH1A1
SCHEMBL5814834 0.69 IDH1 (0.53) L3MBTL1GAALMNA
SCHEMBL6203131 0.69 CYP2C19 (0.66) RAB9ASMN1; SMN2NPC1ALDH1A1MEN1
SCHEMBL28321405 0.69 SRD5A2 (0.57) CES2CES1MAPTL3MBTL1SMN1; SMN2
SCHEMBL17477706 0.68 FNTA (0.53) CES2CES1MAPTL3MBTL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291432-B1 (R)-N-(2-METHYLBENZYL)-3-((2S, 3S)-3-(N-(2-CHROMONECARBONYL)-L-ASPARAGINYL)AMINO-2-HYDROXY-4-PHENYLBUTANO YL)-5,5-DIMETHYL-1,3-THIAZOLIDINE-4-CARBOXAMIDE CAN BE GIVEN AS A TYPICAL EXAMPLE OF THIS COMPOUND. JAPAN ENERGY CORPORATION (JP) 2001-09-18 US disclosed
EP-0900566-A1 NOVEL TRIPEPTIDE COMPOUNDS AND ANTI-AIDS DRUGS JAPAN ENERGY CORPORATION (JP) 1999-03-10 EP disclosed